1. Home
  2. FNWD vs ALGS Comparison

FNWD vs ALGS Comparison

Compare FNWD & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Finward Bancorp

FNWD

Finward Bancorp

N/A

Current Price

$42.55

Market Cap

189.1M

Sector

Finance

ML Signal

N/A

Logo Aligos Therapeutics Inc.

ALGS

Aligos Therapeutics Inc.

HOLD

Current Price

$1.39

Market Cap

34.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNWD
ALGS
Founded
1994
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
189.1M
34.6M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
FNWD
ALGS
Price
$42.55
$1.39
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
★ $36.88
AVG Volume (30 Days)
10.4K
★ 64.0K
Earning Date
10-27-2026
11-06-2026
Dividend Yield
★ 1.11%
N/A
EPS Growth
N/A
★ 88.30
EPS
★ 1.32
N/A
Revenue
N/A
★ $2,186,000.00
Revenue This Year
$10.81
$1,433.30
Revenue Next Year
$5.26
N/A
P/E Ratio
$32.80
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$30.05
$1.58
52 Week High
$45.90
$13.69

Technical Indicators

Market Signals
Indicator
FNWD
ALGS
Relative Strength Index (RSI) 43.33 17.42
Support Level $41.08 N/A
Resistance Level $44.01 $7.79
Average True Range (ATR) 0.71 0.53
MACD -0.15 -0.30
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
FNWD
ALGS

About FNWD Finward Bancorp

Finward Bancorp is a bank holding company that engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Savings Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out throughout the United States. The Company operates as a single reportable segment that derives its revenue mainly from the business of banking.

About ALGS Aligos Therapeutics Inc.

Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.

Share on Social Networks: